Despite the Trump Administration’s proposals to cut US science funding over the last few months, the 2017 Consolidated Appropriations Act, or omnibus bill, indicates a 5.0% rise in total FY17 science R&D to $155.8 billion, according to recent estimates from the American Association for the Advancement of Science (AAAS). Signed into law on May 5, the $1.07 trillion bill is 1.3% higher than the Administration’s requested amount, and a 7.0% decrease from FY16. The AAAS estimates that basic research funding increased 4.1% to $34.9 billion, while applied research funding increased 6.3% to $40.2 billion. R&D funding estimates for development rose 4.0% to $78.1 billion, and facilities and equipment funding increased an estimated 2.9%, totaling $2.7 million. Funding for defense and non defense R&D is estimated to have grown by 6.3% to $82.9 billion and 3.6% to $72.9 billion, representing 53% and 46% of total FY17 science R&D, respectively.
The information in this article is the result of IBO estimates, unless otherwise indicated. The estimates for FY17 are based on Congressional documents, White House explanatory statements and Appropriations Committee press releases.